Peter Heerma

Track

Insider profile

Currently holds a position at Travere Therapeutics Inc

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 67% 68% 82%
Transactions
16 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Commercial Officer Travere Therapeutics Inc Oct. 1, 2019 -
Peter Heerma's trades of Travere Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
179.09
Quantity 53,896
Value US$2,995,817
Transaction date
Proposed sale
Price
62.51
Quantity 172,717
Value US$10,796,540
Transaction date
Proposed sale
Price
40.00
Quantity 4,980
Value US$199,200
Transaction date
Proposed sale
Price
35.00
Quantity 5,591
Value US$195,685
Transaction date
Proposed sale
Price
30.00
Quantity 2,662
Value US$79,860
Transaction date
Proposed sale
Price
25.00
Quantity 3,074
Value US$76,850
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-17 2026-09-17
PlS Planned sale
10,076 -5.9%
492.81
US$460,836 		10,076 -5.9% 492.81 US$460,836
2026-09-17 2026-09-17
PrS Proposed sale
53,896
179.09
US$2,995,817 		53,896 179.09 US$2,995,817
2026-09-17 2026-09-16
PlS Planned sale
77,460 +42.0%
148.47
US$4,378,190 		77,460 +42.0% 148.47 US$4,378,190
2026-09-17 2026-09-16
PlS Planned sale
93,604 -32.3%
63.25
US$5,920,182 		93,604 -32.3% 63.25 US$5,920,182
2026-09-16 2026-09-16
PrS Proposed sale
172,717
62.51
US$10,796,540 		172,717 62.51 US$10,796,540
2026-09-17 2026-09-15
PlS Planned sale
1,431 -1.2%
65.31
US$93,458 		1,431 -1.2% 65.31 US$93,458
2026-09-17 2026-09-15
PlS Planned sale
1,400 -1.2%
63.65
US$89,113 		1,400 -1.2% 63.65 US$89,113
2026-09-17 2026-09-15
PlS Planned sale
27,421 -18.6%
62.59
US$1,716,379 		27,421 -18.6% 62.59 US$1,716,379
2026-09-17 2026-09-15
PlS Planned sale
71,938 -32.8%
62.05
US$4,463,875 		71,938 -32.8% 62.05 US$4,463,875
2026-09-15 2026-09-15
PrS Proposed sale
102,190
65.79
US$6,723,080 		102,190 65.79 US$6,723,080
2026-05-06 2026-05-05
S Sale
2,174 -1.5%
46.65
US$101,417 		2,174 -1.5% 46.65 US$101,417
2026-05-05 2026-05-05
PrS Proposed sale
2,174
46.65
US$101,417 		2,174 46.65 US$101,417
2026-04-15 2026-04-14
S Sale
7,215 -4.9%
41.93
US$302,516 		7,215 -4.9% 41.93 US$302,516
2026-04-14 2026-04-14
PrS Proposed sale
7,215
41.93
US$302,516 		7,215 41.93 US$302,516
2026-02-04 2026-02-03
PrS Proposed sale
7,310
32.12
US$234,799 		7,310 32.12 US$234,799
2026-02-03 2026-02-03
S Sale
7,310 -5.3%
32.12
US$234,797 		7,310 -5.3% 32.12 US$234,797
2026-02-03 2026-02-03
S Sale
7,310 -5.3%
32.12
US$234,797 		7,310 -5.3% 32.12 US$234,797
2025-12-29 2025-12-24
PrS Proposed sale
4,980
40.00
US$199,200 		4,980 40.00 US$199,200
2025-12-29 2025-12-24
PlS Planned sale
4,980 -4.2%
40.00
US$199,200 		4,980 -4.2% 40.00 US$199,200
2025-11-04 2025-10-31
PlS Planned sale
5,591 -4.5%
35.00
US$195,685 		5,591 -4.5% 35.00 US$195,685
2025-10-31 2025-10-31
PrS Proposed sale
5,591
35.00
US$195,685 		5,591 35.00 US$195,685
2025-10-30 2025-10-28
PlS Planned sale
2,662 -2.1%
30.00
US$79,860 		2,662 -2.1% 30.00 US$79,860
2025-10-28 2025-10-28
PrS Proposed sale
2,662
30.00
US$79,860 		2,662 30.00 US$79,860
2025-05-05 2025-05-05
PrS Proposed sale
1,771
21.05
US$37,280 		1,771 21.05 US$37,280
2025-05-05 2025-05-05
S Sale
1,771 -1.4%
21.05
US$37,280 		1,771 -1.4% 21.05 US$37,280
2025-02-12 2025-02-12
PrS Proposed sale
2,568
23.53
US$60,426 		2,568 23.53 US$60,426
2025-02-12 2025-02-12
S Sale
2,568 -2.0%
23.53
US$60,426 		2,568 -2.0% 23.53 US$60,426
2025-02-12 2025-02-11
PlS Planned sale
3,074 -2.4%
25.00
US$76,850 		3,074 -2.4% 25.00 US$76,850
2025-02-11 2025-02-11
PrS Proposed sale
3,074
25.00
US$76,850 		3,074 25.00 US$76,850
2025-02-04 2025-02-03
S Sale
5,166 -4.0%
20.12
US$103,940 		5,166 -4.0% 20.12 US$103,940
2025-02-03 2025-02-03
PrS Proposed sale
5,166
20.12
US$103,934 		5,166 20.12 US$103,934
2025-01-23 2025-01-22
S Sale
1,584 -1.5%
18.94
US$30,002 		1,584 -1.5% 18.94 US$30,002
2024-09-09 2024-09-09
S Sale
2,191 -2.0%
11.52
US$25,240 		2,191 -2.0% 11.52 US$25,240
2024-02-02 2024-02-01
S Sale
4,195 -4.0%
8.53
US$35,789 		4,195 -4.0% 8.53 US$35,789
2024-02-01 2024-02-01
PrS Proposed sale
4,195
8.53
US$35,800 		4,195 8.53 US$35,800
2024-01-25 2024-01-23
S Sale
1,559 -1.9%
9.07
US$14,138 		1,559 -1.9% 9.07 US$14,138
2023-10-04 2023-10-03
S Sale
3,091 -3.7%
8.25
US$25,504 		3,091 -3.7% 8.25 US$25,504
2023-02-02 2023-02-01
S Sale
1,779 -2.1%
21.75
US$38,697 		1,779 -2.1% 21.75 US$38,697
2023-01-26 2023-01-24
S Sale
1,550 -2.4%
21.90
US$33,952 		1,550 -2.4% 21.90 US$33,952
2022-10-06 2022-10-04
S Sale
3,042 -4.5%
25.68
US$78,119 		3,042 -4.5% 25.68 US$78,119
2022-02-02 2022-01-31
PlS Planned sale
1,125 -1.6%
27.40
US$30,825 		1,125 -1.6% 27.40 US$30,825
2022-01-26 2022-01-24
PlS Planned sale
1,875 -3.1%
24.98
US$46,838 		1,875 -3.1% 24.98 US$46,838
2021-10-05 2021-10-04
S Sale
3,058 -4.8%
24.77
US$75,746 		3,058 -4.8% 24.77 US$75,746
2021-02-09 2021-02-08
PlS Planned sale
1,125 -1.9%
31.58
US$35,528 		1,125 -1.9% 31.58 US$35,528
2021-02-09 2021-02-05
PlS Planned sale
1,125 -1.8%
31.41
US$35,336 		1,125 -1.8% 31.41 US$35,336